Children exposed to antiretroviral (ARV) therapy in utero and not exposed to HIV showed no difference in language development ...
After 96 weeks, 4% taking TAF/emtricitabine and 16% taking TDF/emtricitabine had a 5% or greater drop in spine bone mass density. Two people out of 2694 people taking TAF/emtricitabine stopped ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback